121 related articles for article (PubMed ID: 24623243)
1. Detection and characterization of oncogene mutations in preneoplastic and early neoplastic lesions.
Minamoto T
Methods Mol Biol; 2014; 1105():381-98. PubMed ID: 24623243
[TBL] [Abstract][Full Text] [Related]
2. Detection and Characterization of Oncogene Mutations in Preneoplastic and Early Neoplastic Lesions.
Minamoto T
Methods Mol Biol; 2020; 2102():419-437. PubMed ID: 31989570
[TBL] [Abstract][Full Text] [Related]
3. Detection and characterization of oncogene mutations in preneoplastic and early neoplastic lesions.
Minamoto T
Methods Mol Biol; 2005; 291():263-78. PubMed ID: 15502229
[TBL] [Abstract][Full Text] [Related]
4. The role of K-RAS and B-RAF mutations as biomarkers in metastatic colorectal cancer.
Selcukbiricik F; Erdamar S; Ozkurt CU; Molinas Mandel N; Demirelli F; Ozguroglu M; Tural D; Buyukunal E; Serdengecti S
J BUON; 2013; 18(1):116-23. PubMed ID: 23613396
[TBL] [Abstract][Full Text] [Related]
5. Detection of point mutations of K-ras oncogene and p53 tumor-suppressor gene in sputum samples.
Gao W; Keohavong P
Methods Mol Biol; 2014; 1105():325-44. PubMed ID: 24623240
[TBL] [Abstract][Full Text] [Related]
6. A novel high-specificity approach for colorectal neoplasia: Detection of K-ras2 oncogene mutation in normal mucosa.
Yamada S; Yashiro M; Maeda K; Nishiguchi Y; Hirakawa K
Int J Cancer; 2005 Mar; 113(6):1015-21. PubMed ID: 15514939
[TBL] [Abstract][Full Text] [Related]
7. Analysis of K-ras, BRAF, and PIK3CA mutations in laterally-spreading tumors of the colorectum.
Kaji E; Kato J; Suzuki H; Akita M; Horii J; Saito S; Higashi R; Ishikawa S; Kuriyama M; Hiraoka S; Uraoka T; Yamamoto K
J Gastroenterol Hepatol; 2011 Mar; 26(3):599-607. PubMed ID: 21332555
[TBL] [Abstract][Full Text] [Related]
8. K-ras mutations in circulating DNA from pancreatic and lung cancers: bridging methodology for a common validation of the molecular diagnosis value.
Magistrelli P; Neri M; Granone P; Cesario A; Paleari L; Russo P
Pancreas; 2008 Jul; 37(1):101-2. PubMed ID: 18580451
[No Abstract] [Full Text] [Related]
9. Prognostic significance of alterations in KRAS isoforms KRAS-4A/4B and KRAS mutations in colorectal carcinoma.
Abubaker J; Bavi P; Al-Haqawi W; Sultana M; Al-Harbi S; Al-Sanea N; Abduljabbar A; Ashari LH; Alhomoud S; Al-Dayel F; Uddin S; Al-Kuraya KS
J Pathol; 2009 Dec; 219(4):435-45. PubMed ID: 19824059
[TBL] [Abstract][Full Text] [Related]
10. Concomitant mutations and splice variants in KRAS and BRAF demonstrate complex perturbation of the Ras/Raf signalling pathway in advanced colorectal cancer.
Seth R; Crook S; Ibrahem S; Fadhil W; Jackson D; Ilyas M
Gut; 2009 Sep; 58(9):1234-41. PubMed ID: 19474002
[TBL] [Abstract][Full Text] [Related]
11. Detection of KRAS mutations in colorectal cancer with Fast COLD-PCR.
Carotenuto P; Roma C; Cozzolino S; Fenizia F; Rachiglio AM; Tatangelo F; Iannaccone A; Baron L; Botti G; Normanno N
Int J Oncol; 2012 Feb; 40(2):378-84. PubMed ID: 21971641
[TBL] [Abstract][Full Text] [Related]
12. Use of K-Ras as a predictive biomarker for selecting anti-EGF receptor/pathway treatment.
Jiang Y; Mackley H; Cheng H; Ajani JA
Biomark Med; 2010 Aug; 4(4):535-41. PubMed ID: 20701442
[TBL] [Abstract][Full Text] [Related]
13. Copy number alterations of chromosomal regions enclosing protein tyrosine phosphatase receptor-like genes in colorectal cancer.
Laczmanska I; Karpinski P; Kozlowska J; Bebenek M; Ramsey D; Sedziak T; Ziolkowski P; Sasiadek MM
Pathol Res Pract; 2014 Dec; 210(12):893-6. PubMed ID: 25169130
[TBL] [Abstract][Full Text] [Related]
14. Frequency of Ki-ras mutations and DNA alkylation in colorectal tissue from individuals living in Manchester.
Jackson PE; Hall CN; Badawi AF; O'Connor PJ; Cooper DP; Povey AC
Mol Carcinog; 1996 May; 16(1):12-9. PubMed ID: 8634090
[TBL] [Abstract][Full Text] [Related]
15. Clinicopathological and protein characterization of BRAF- and K-RAS-mutated colorectal cancer and implications for prognosis.
Zlobec I; Bihl MP; Schwarb H; Terracciano L; Lugli A
Int J Cancer; 2010 Jul; 127(2):367-80. PubMed ID: 19908233
[TBL] [Abstract][Full Text] [Related]
16. Role of oncogenic K-Ras in cancer stem cell activation by aberrant Wnt/β-catenin signaling.
Moon BS; Jeong WJ; Park J; Kim TI; Min do S; Choi KY
J Natl Cancer Inst; 2014 Feb; 106(2):djt373. PubMed ID: 24491301
[TBL] [Abstract][Full Text] [Related]
17. Stage III & IV colon and rectal cancers share a similar genetic profile: a review of the Oregon Colorectal Cancer Registry.
Gawlick U; Lu KC; Douthit MA; Diggs BS; Schuff KG; Herzig DO; Tsikitis VL
Am J Surg; 2013 May; 205(5):608-12; discussion 612. PubMed ID: 23592171
[TBL] [Abstract][Full Text] [Related]
18. A gene marker panel covering the Wnt and the Ras-Raf-MEK-MAPK signalling pathways allows to detect gene mutations in 80% of early (UICC I) colon cancer stages in humans.
Scholtka B; Schneider M; Melcher R; Katzenberger T; Friedrich D; Berghof-Jäger K; Scheppach W; Steinberg P
Cancer Epidemiol; 2009 Aug; 33(2):123-9. PubMed ID: 19679059
[TBL] [Abstract][Full Text] [Related]
19. Highly methylated genes in colorectal neoplasia: implications for screening.
Zou H; Harrington JJ; Shire AM; Rego RL; Wang L; Campbell ME; Oberg AL; Ahlquist DA
Cancer Epidemiol Biomarkers Prev; 2007 Dec; 16(12):2686-96. PubMed ID: 18086775
[TBL] [Abstract][Full Text] [Related]
20. Molecular mechanisms underlying the tumorigenesis of colorectal adenomas: correlation to activated K-ras oncogene.
Wang JY; Wang YH; Jao SW; Lu CY; Kuo CH; Hu HM; Hsieh JS; Chong IW; Cheng TL; Lin SR
Oncol Rep; 2006 Dec; 16(6):1245-52. PubMed ID: 17089045
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
